The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1084-1092

  Frisco, Marco ^a   Hongo, Atsushi ^a   Rizzo, Maria Giulia ^b   Sacchi, Ada ^b   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; PROTEIN P53; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; GENE EXPRESSION; HEMATOPOIETIC CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; TEMPERATURE SENSITIVE MUTANT;

ANIMALIA; MURINAE;

EID: 0031036879     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.3.1084     Document Type: Article

References (56)

1. Araki, E., M. A. Lipes, M. E. Patti, J. S. Bruning, B. Haag III, R. S. Johnson, and C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 272:186-190.
2. Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
3. Baker, J., J.-P. Liu, E. J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 73:73-82.
4. Baserga, R. 1994. Oncogenes and the strategy of growth factors. Cell 79: 927-930.
5. Baserga, R. 1995. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res. 55:249-252.
6. Blandino, G., R. Scardigli, M. G. Rizzo, M. Crescenzi, S. Soddu, and A. Sacchi. 1995. Wild-type p53 modulates apoptosis of normal, IL-3 deprived. hematopoietic cells. Oncogene 10:731-737.
7. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B. R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649.
8. Canman, C. E., T. M. Gilmer, S. B. Coutts, and M. B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9:600-611.
9. Coppola, D., A. Ferber, M. Miura, C. Sell, C. D'Ambrosio, R. Rubin, and R. Baserga. 1994. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14:4588-4595.
10. D'Ambrosio, C., A. Ferber, M. Resnicoff, and R. Baserga. 1996. A soluble insulin-like growth factor 1 receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56:4013-4020.
11. Deb, S. P., R. M. Munoz, D. R. Brown, M. A. Subler, and S. Deb. 1994. Wild type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9:1341-1349.
12. de la Luna, S., I. Soria, D. Pulido, J. Ortin, and A. Jimenez. 1988. Efficient transformation of mammalian cells with constructs containing a puromycin-resistance marker. Gene 62:121-126.
13. D'Mello, S. R., C. Galli, T. Ciotti, and P. Calissano. 1993. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90: 10989-10993.
14. Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542.
15. Gluckman, P., N. Klempt, J. Guan, C. Mallard, E. Sirimanne, M. Dragunow, M. Klempt, K. Singh, C. Williams, and K. Nikolics. 1992. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 182:593-599.
16. Greenberger, S., M. A. Sakakeeny, R. K. Humphries, C. J. Eaves, and R. J. Eckner. 1983. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. USA 80:2931-2935.
17. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
18. Hongo, A., C. D'Ambrosio, M. Miura, A. Morrione, and R. Baserga. 1996. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12:1231-1238.
19. Jung, Y. K., M. Miura, and J. Yuan. 1996. Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor. J. Biol. Chem. 271:5112-5117.
20. Lenahan, M. K., and H. L. Ozer. 1996. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts. Oncogene 12:1847-1854.
21. Liu, J.-P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type 1 IGF receptor (igf1r). Cell 75:54-72.
22. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
23. McCubrey, J. A., L. S. Stillman, M. W. Mayhew, P. A. Algate, R. A. Dellow, and M. Kaleko. 1991. Growth promoting effects of insulin-like growth factor I (IGF-1) on hematopoietic cells. Overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor dependent cells by ligand dependent mechanism. Blood 78:921-929.
24. Mendez, R., M. G. Myers, Jr., M. F. White, and R. E. Rhoads. 1996. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-1 phosphorylation by insulin requires insulin receptor substrate-1 and phosphatidylinositol 3-kinase. Mol. Cell. Biol. 16:2857-2864.
25. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
26. Miyashita, T., T. Krajevski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
27. Myers, M. J., X. J. Sun, B. Cheatham, B. R. Jachna, E. M. Glasheen, J. M. Backer, and M. F. White. 1993. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132:1421-1430.
28. O'Connor, R., A. Kauffmann-Zeh, Y. Liu, S. Lehar, G. I. Evan, R. Baserga, and W. A. Blättler. 1997. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol. 17:427-435
29. Pietrzkowski, Z., R. Lammers, G. Carpenter, A. M. Soderquist, M. Limardo, P. D. Phillips, A. Ullrich, and R. Baserga. 1992. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ. 3:199-205.
30. Resnicoff, M., D. Abraham, W. Yutanawiboonchai, H. Rotman, J. Kajstura, R. Rubin, P. Zoltick, and R. Baserga. 1995. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:2463-2469.
31. Resnicoff, M., J.-L. Burgaud, H. L. Rotman, D. Abraham, and R. Baserga. 1995. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor I receptors. Cancer Res. 55:3739-3741.
32. Rodriguez-Tarduchy, G., M. K. L. Collins, I. Garcia, and A. Lopez-Rivas. 1992. Insulin-like growth factor I inhibits apoptosis in IL-3 dependent hemopoietic cells. J. Immunol. 149:535-540.
33. Rubini, M., H. Werner, E. Gandini, C. T. Roberts, Jr., D. LeRoith, and R. Baserga. 1994. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene. Exp. Cell Res. 211:374-379.
34. Rubini, M., A. Hongo, C. D'Ambrosio, and R. Baserga. The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Exp. Cell Res., in press.
35. Scatchard, G. 1949. The attractions of proteins to small molecules and ions. Ann. N. Y. Acad. Sci. 51:660-672.
36. Sell, C., R. Baserga, and R. Rubin. 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55:303-306.
37. Sell, C., G. Dumenil, C. Deveaud, M. Miura, D. Coppola, T. DeAngelis, R. Rubin, A. Efstratiadis, and R. Baserga. 1994. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14:3604-3612.
38. Sell, C., M. Rubini, R. Rubin, J.-P. Liu, A. Efstratiadis, and R. Baserga. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad. Sci. USA 90:11217-11221.
39. Sell, C., T. Ptasznik, C. D. Chang, J. Swantek, V. J. Cristofalo, and R. Baserga. 1993. IGF-I receptor levels and the proliferation of young and senescent fibroblasts. Biochem. Biophys. Res. Commun. 194:259-265.
40. Soddu, S., G. Blandino, R. Scardigli, R. Martinelli, M. G. Rizzo, M. Crescenzi, and A. Sacchi. 1996. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol. 16:487-495.
41. Stiles, C. D., G. T. Capone, C. D. Scher, N. H. Antoniades, J. J. Van Wyk, and W. J. Pledger. 1979. Dual control of cell growth by somatomedins and platelet derived growth factor. Proc. Natl. Acad. Sci. USA 76:1279-1283.
42. Surmacz, E., C. Sell, J. Swantek, H. Kato, C. T. Roberts, Jr., D. LeRoith, and R. Baserga. 1995. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor I receptor. Exp. Cell Res. 218:370-380.
43. Thulasi, R., P. Dias, P. J. Houghton, and J. A. Houghton. 1996. a2a interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type 1 receptor. Cell Growth Differ. 7:531-541.
44. Ullrich, A., A. Gray, A. W. Tam, T. Yang-Feng, M. Tsubokawa, C. Collins, W. Henzel, T. Le Bon, S. Kahuria, E. Chen, S. Jakobs, U. Francke, J. Ramachandran, and Y. Fujita-Yamaguchi. 1986. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5:2503-2512.
45. Valentinis, B., and R. Baserga. 1996. The IGF-I receptor protects tumor cells from apoptosis induced by high concentrations of serum. Biochem. Biophys. Res. Commun. 224:362-368.
46. Wang, L. M., M. G. Myers, Jr., X. J. Sun, S. A. Saronson, M. White, and J. Pierce. 1993. IRS-1: essential for insulin and IL-4-stimulated mitogenesis in hemopoietic cells. Science 261:1591-1594.
47. Webster, N. J. G., J. L. Resnik, D. B. Reichart, B. Strauss, M. Haus, and B. L. Seely. 1996. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res. 56:2781-2788.
48. Werner, H., M. A. Bach, B. Stannard, C. T. Roberts, Jr., and D. LeRoith. 1992. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol. 6:1545-1556.
49. Werner, H., Z. Shen-Orr, F. J. Rauscher, J. F. Morris, C. T. Roberts, Jr., and D. LeRoith. 1995. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol. 15:3516-3522.
50. Werner, H., B. Stannard, M. A. Bach, D. LeRoith, and C. T. Roberts, Jr. 1990. Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor 1 (IGF-1) receptor gene. Biochem. Biophys. Res. Commun. 169:1021-1027.
51. Werner, H., E. Karnieli, F. J. Rauscher III, and D. LeRoith. 1996. Wild type and mutant p53 differentially regulate transcription of insulin-like growth factor 1 receptor gene. Proc. Natl. Acad. Sci. USA 93:8318-8323.
52. Yamauchi, K., and J. E. Pessin. 1994. Enhancement or inhibition of insulin signaling by insulin receptor substrate 1 is cell context dependent. Mol. Cell. Biol. 14:4427-4434.
53. Yenush, L., R. Fernandez, M. Myers, T. C. Grammer, X. J. Sun, J. Blenis, J. H. Pierce, J. Schlessinger, and M. P. White. 1996. The Drosophila insulin receptor activates multiple signaling pathways but requires insulin receptor substrate proteins for DNA synthesis. Mol. Cell. Biol. 16:2509-2517.
54. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J. J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1415-1423.
55. Zhang, L., F. Kashanchi, Q. Zhan, J. N. Brady, A. J. Fornace, P. Seth, and L. J. Helman. 1996. Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis. Cancer Res. 56:1367-1373.
56. Zumstein, P. P., C. Luthi, and R. E. Humbel. 1985. Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc. Natl. Acad. Sci. USA 82:3169-3172.